Evidence map›Paper›PMID 32701196›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2021

Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients.

Aileen X Wang, Orlando Quintero Cardona, Dora Y Ho, Stephan Busque, Colin R Lenihan

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Impact of COVID-19 in solid organ transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Review
  10. Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  11. Observational
  12. Perspectives of Neuro-COVID: Myasthenia.Frontiers in neurology · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aileen X WangDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID https://orcid.org/0000-0002-1097-9270
Orlando Quintero CardonaDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Dora Y HoDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stephan BusqueDivision of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.ORCID https://orcid.org/0000-0003-1048-1621
Colin R LenihanDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid organ transplant recipients are at risk for infectious complications due to chronic immunosuppression. The outbreak of coronavirus disease 2019 (COVID-19) in the United States has raised growing concerns for the transplant patient population. We seek to add to the current limited literature on COVID-19 in transplant recipients by describing the clinical course of two kidney transplant recipients with SARS-CoV-2 infection monitored by both RT-PCR and serology. Through careful adjustment of their immunosuppression regimen, both patients had excellent recovery with intact graft function and development of anti-SARS-CoV-2 antibodies.

Indexed as

Kidney TransplantationSARS-CoV-2Transplant RecipientsAgedFemaleHumansImmunocompromised HostImmunosuppressive AgentsMiddle AgedSeroconversionImmunosuppressive AgentsantibodiesCOVID-19immunosuppressionRT-PCRSARS-CoV-2seroconversion

Identifiers

PMID32701196
PMCPMC7404350
OpenAlexW3044162366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.